Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Estee Lauder Cuts Annual Forecasts as China Curbs Drag Demand

Estee Lauder Cos Inc cut its full-year sales and profit forecasts on Wednesday, signaling a hit to sales from persistent COVID-19-related lockdowns and store closures in major market China. The New York-based company's shares were down about 5% in premarket trade. Sales growth of many US companies like Estee has…

Asharq Al-Awsat

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

CVS Health agrees to $5B settlement of opioid lawsuits

CVS Health says it has agreed to pay about $5 billion to state, local and Native American tribal governments to settle lawsuits over the toll of opioids

The Independent UK

The WHO says monkeypox is still a global health emergency of concern, despite a 'promising' decline in cases

Despite a promising decline in global cases, the World Health Organization has determined that monkeypox should remain a "public health emergency of international concern". Here's why.

ABC News

The health care cost wars may be coming to a head

If they do, the political fallout will be defined by industry group brawling.

Axios

A Multi-National Mega Corp Trialled The 4-Day Work Week Got Great Results So Let’s Goooo

If even Unilever, of all companies, is allowing its staff a 4 day work week then we know that shit works.

Pedestrian.tv

Read news from The Economist, FT, and more,
with one subscription

CSL paying $312m to license mRNA vax tech

CSL Seqirus is paying $A312 million up-front to license next-generation mRNA technology from a small US company, Arcturus Therapeutics.

AAP

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study

Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation.

Benzinga

Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder

Specialty biopharma company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has entered into an evaluation and exclusive option agreement with Case Western Reserve University (CWRU)

Benzinga

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.

Benzinga

The Worst Biotech Stocks Investors Could Buy This Fall

Timber Pharmaceuticals (TMBR) recently received an NYSE warning for not meeting the minimum trading price requirement for quite some time. The stock has lost 84% year-to-date. Given the company’s weak fundamentals, the stock could be a poor choice for investors enticed by its negligible price. Let’s discuss….

StockNews.com

Australian workers to trial four-day week

Consumer goods giant Unilever is expanding its four-day work week trial to Australia after impressive results in New Zealand.

AAP

How coal miners and factory workers helped found the environmental movement

Rachel Carson, a scientist and writer from rural Pennsylvania, published Silent Spring 60 years ago. Many credit this book, which meticulously documented the damage that DDT pesticides were inflicting on wildlife, farm animals and people as early as the 1950s, with launching the modern environmental movement.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Three Pillars of Effective Ketamine Mental Health Treatment

By Kevin Nicholson, COO of Delic and CEO of Ketamine Wellness Centers

Benzinga

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More

15 Global Psychedelics Executives To Keep An Eye On In 2022

The Walrus

Ask an Immunity Expert: What’s Next for COVID-19?

This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force

The Independent UK

Indonesia revokes drug companies' licenses after 159 deaths

Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159 children due to acute kidney injury

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

Axios

RSV vaccine search could hit third piece of "tripledemic" threat

We've got COVID boosters and flu shots. But there's a missing piece in this triad of tools to cope with what's been dubbed the tripledemic: an RSV vaccine. That could soon change.

The Independent UK

Strong RSV vaccine data lifts hopes after years of futility

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV

The Independent UK

Covid remains deadly for half a million Britons, and the government isn’t talking about it

As immunocompromised people and their families face a third housebound winter, Charlotte Lytton asks why the government is dragging its feet when it comes to the possibly life-altering drug Evusheld. It remains punishingly out of reach… unless you cough up the money for it

Tribune News Service

Study finds COVID-19 symptoms recur more often in those who took Paxlovid to ease illness

SAN DIEGO — You've been free of COVID-19 symptoms for two days. Then the coughing, fatigue and headaches return. Join the growing number of people experiencing what's being called COVID rebound.

1 … 108 109 110 111

People

Rob

918 stories

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Michigan State University

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.